Complera (rilpivirine/tenofovir/emtricitabine) is a multi-class combination drug used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in adults with an HIV viral load less than or equal to 100,000 copies/mL. It is listed in the DHHS HIV treatment guidelines as an alternative regimen for people starting HIV treatment for the first time.
Adult single dose: Take one tablet once daily. Each tablet contains 200 mg of emtricitabine, 25 mg of rilpivirine, and 300 mg of tenofovir disoproxil fumarate.
News & Research